{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:10:45Z","timestamp":1784740245230,"version":"3.55.0"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0170847","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T13:54:56Z","timestamp":1485438896000},"page":"e0170847","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-6706","authenticated-orcid":true,"given":"Hadas","family":"Stiebel-Kalish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Andrew","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08820538.2015.1114835","article-title":"Investigation-Directed Approach to Inflammatory Optic Neuropathies","volume":"31","author":"K Boudreault","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"DM Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"DK Sato","year":"2014","journal-title":"Neurology"},{"key":"ref4","article-title":"Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies","author":"K Kaneko","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","author":"S Ramanathan","year":"2015","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"S Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"J Kitley","year":"2012","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"I Kleiter","year":"2016","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"A Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref10","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","author":"DM Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","article-title":"The OSCAR-IB consensus criteria for retinal OCT quality assessment","volume":"7","author":"P Tewarie","year":"2012","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","article-title":"The APOSTEL recommendations for reporting quantitative optical coherence tomography studies","volume":"86","author":"A Cruz-Herranz","year":"2016","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT)","volume":"247","author":"C Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test","volume":"47","author":"K Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","article-title":"MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study","volume":"87","author":"T Akaishi","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","article-title":"Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD","author":"JJ Wang","year":"2016","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ana.24608","article-title":"Clinicopathological features in anterior visual pathway in neuromyelitis optica","volume":"79","author":"M Hokari","year":"2016","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12974-016-0577-8","article-title":"Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid","volume":"13","author":"R Marignier","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"VA Lennon","year":"2004","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"S Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"F Pache","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"R Hoftberger","year":"2015","journal-title":"Mult Scler"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1212\/WNL.0b013e31826aadaf","article-title":"Antibodies to MOG in NMO: a seasoned veteran finds a new role","volume":"79","author":"HJ Willison","year":"2012","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1167\/iovs.10-7108","article-title":"Application of advanced statistics in ophthalmology","volume":"52","author":"Q Fan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0170847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:54:15Z","timestamp":1540338855000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0170847"}},"subtitle":[],"editor":[{"given":"Friedemann","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0170847","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}